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ABSTRACT 
 
English Version 
 
Title: The self-efficacy for coping and quality of life in women with Breast Cancer in Hospital 
Universiti Sains Malaysia. 
 
Introduction: Breast cancer is the second most common cancer in the world and the commonest 
cancer in Malaysia. High level of self-efficacy for coping in breast cancer survivors has a 
positive effect on health behaviors, symptom control, compliance with cancer treatment, as well 
as on quality of life (QoL). This study aims to determine the self-efficacy for coping scores and 
its association with socio-demographic and clinical variables. As well as to determine the global, 
functional and symptoms QoL and its correlation with self-efficacy for coping within 3 years of 
diagnosis in breast cancer women in Hospital Universiti Sains Malaysia.  
 
Methodology: This is a cross sectional study involving 168 women diagnosed with breast cancer 
between January 1, 2009 and December 31, 2012. The universal sampling method was applied 
following inclusion and exclusion criteria recruited from January 2012 to December 2012. The 
inclusion criteria were age >18 years old, histologically confirmed breast cancer and cancer was 
diagnosed from January 2009 until December 2012. The exclusion criteria were illiterate and 
diagnosed with cognitive impairment. A self-administered/self-guided questionnaire used to 
obtain the socio-demographic and clinical characteristics, self-efficacy for coping and QoL. The 
x 
 
brief Cancer Behavior inventory (CBI-B) and the European Organization for Research and 
Treatment of Cancer (EORTC) with breast cancer’s questionnaires were used. Patients’ medical 
record was used for detail information about medical/clinical data. The data were analyzed by 
using multiple linear regressions and Spearman rank correlation. 
 
Result: The mean score of self-efficacy for coping in breast cancer women was 83.67 (95% CI: 
81.87, 85.47). The positive impact on self-efficacy for coping were higher educational levels 
(β=7.26, p<0.001) and good income (β=0.001, p=0.021). However, positive family history of 
breast cancer (β=-5.43, p=0.008), and performed breast cancer surgery (β=-16.44, p=0.003) 
reduced the self-efficacy for coping. The mean of global QoL was 59.9 (95% CI 56.7, 63.0). The 
global QoL (r=0.407 p<0.001), and functioning QoL subscales (r ranged from 0.191 to 0.308, 
p<0.05) were significant positive correlation with self-efficacy for coping, but symptoms QoL 
subscales (r ranged from -0.157 to -0.282, p<0.05) had significant negative correlation with self-
efficacy for coping.   
 
Conclusion: The self-efficacy for coping mean score was moderate in breast cancer women. 
Higher educational levels and good income increased the self-efficacy for coping. However, 
positive family history of breast cancer and breast cancer surgery reduced the self-efficacy for 
coping. The global QOL mean score was slightly below average in this study and the functional 
QoL had a significant positive correlation with self-efficacy for coping. But, symptoms QOL had 
a significant negative correlation with self-efficacy for coping.  
xi 
 
Malay version  
 
Tajuk: Kecekapan diri untuk mengatasi dan kualiti kehidupan penghidap kanser payudara 
wanita di Hospital Universiti Sains Malaysia. 
Pengenalan: Kanser payudara adalah yang kedua tertinggi di dunia dan yang paling ramai di 
kesan di Malaysia. Kecekapan diri untuk mengatasi yang tinggi dalam penghidap kanser 
payudara memberi kesan yang positif kepada cara hidup sihat, kawalan simptom, kepatuhan pada 
rawatan kanser, dan juga taraf kualiti kehidupan. Kajian ini bertujuan untuk mengenalpasti skor 
min kecekapan diri pesakit untuk mengatasi barah payudara, kaitannya dengan sosiodemografik 
dan klinikal data. Juga, untuk mengenalpasti skor min kualiti kehidupan global, fungsi dan 
simptom dalam jangka masa 3 tahun di sahkan menghidap kanser payudara dan hubungkaitnya 
dengan kecekapan diri pesakit kanser payudara wanita untuk mengatasi kanser di Hospital 
Universiti Sains Malaysia  
 
Kaedah Kajian: Kajian ini adalah secara keratan rentas melibatkan 168 orang wanita yang 
disahkan menghidap barah payudara dari 1 Januari 2009 sehingga 31 Disember 2012. Pemilihan 
sampel dilakukan secara universal berdasarkan kriteria kemasukan dan penolakan bermula dari 
Januari 2012 hingga Disember 2012. Kriteria kemasukan adalah pesakit kanser payudara 
berumur 18 tahun ke atas, sah menghidap kanser payudara secara histologi, dan kanser di sahkan 
dari Januari 2009 hingga Disember 2012. Kriteria penolakan pula pesakit yang tidak boleh 
membaca dan di sahkan bermasalah dari segi fungsi kognitif. Borang soal-selidik/penjelasan di 
gunakan untuk mendapatkan data berkaitan sosiodemografi dan klinikal, kecekapan diri untuk 
mengatasi dan kualiti kehidupan pesakit. Soalan yang di gunakan adalah ‘brief Cancer Behavior 
xii 
 
Inventory’ dan ‘European Organization for Research and Treatment of Cancer’. Rekod pesakit 
juga di gunakan untuk mendapatkan maklumat klinikal. Data dianalisa menggunakan regresi 
linear berganda dan korelasi ‘Spearman rank’. 
 
Keputusan: Markah purata kecekapan diri untuk mengatasi penyakit kanser payudara wanita 
adalah 83.67 (95% CI: 81.87, 85.47). Tahap pendidikan yang tinggi (β=7.26, p<0.001), dan 
pendapatan yang bagus (β=0.001, p=0.021) menyumbang kepada peningkatan kecekapan diri 
untuk mengatasi. Sebaliknya, sejarah keluarga yang menghidap kanser payudara (β=-5.43, 
p=0.008) dan pembedahan payudara (β=-16.44, p=0.003) mengurangkan tahap kecekapan diri 
untuk mengatasi. Markah purata untuk kualiti kehidupan global adalah 59.9 (95% CI 56.7, 63.0). 
Kualiti kehidupan global (r=0.407, p<0.001) dan subskala fungsi kualiti kehidupan (r di antara 
0.191 hingga 0.308, p<0.05) berhubungkait secara positif dengan kecekapan diri pesakit untuk 
mengatasi kanser payudara tetapi simptom kualiti kehidupan (r di antara -0.157 hingga -0.282, 
p<0.05) berhubungkait secara negatif dengan kecekapan diri untuk mengatasi kanser.   
 
Kesimpulan: Kecekapan diri pesakit wanita untuk mengatasi barah payudara adalah sederhana. 
Tahap pendidikan yang tinggi dan pendapatan yang bagus meningkatkan kecekapan diri untuk 
mengatasi kanser. Tetapi, sejarah keluarga yang menghidap kanser payudara dan pembedahan 
kanser payudara mengurangkan kecekapan diri untuk mengatasi kanser. Skor min kualiti 
kehidupan global adalah bawah sedikit daripada markah purata. Fungsi kualiti kehidupan 
berhubungkait secara positif dengan kecekapan diri untuk mengatasi kanser. Tetapi, simptom 
kualiti kehidupan berhubungkait secara negatif dengan kecekapan diri untuk mengatasi kanser. 
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CHAPTER 1 : INTRODUCTION 
 
 Breast cancer is the second most common cancer worldwide and the commonest 
malignant tumor among women, accounts for more than 1,000,000 new cases worldwide each 
year and more than 375,000 cancer death per year (1). It cause major physical and psychosocial 
health burden in either well developed or less developed countries. 
  In developing countries, the onset of breast cancer is common in the younger age group 
with more aggressive and rare forms of cancer such as inflammatory types (2). On the contrary, 
the disease is prevalent among post-menopausal women in Western countries, in which is 
prominent in the mean age of 60 years old (3). 
In Malaysia, breast cancer is the most common cancer. There were 3,525 female breast 
cancer patients registered in the National Cancer Registry Malaysia in year 2006 and accounted 
as 16.5% of all cancer registered for that year (4, 5). The incidence rate of breast cancer rose 
steadily in which 4,337 in 2002 compared to 3,825 for the year 2000 (4). The disease is 
accounted for 31% of all newly diagnosed female cancer in Malaysia. The latest report from 
cancer registry shows that starting from the age of 30 the incidence of breast cancer is increasing 
in trend and peaks at the 50-59 age group however it reduced in the elderly age group (4). 
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Diagnosed with breast cancer was undeniably distressing and the previous studies show 
that it was associated with negative consequences on physical, mental and social well-being of 
the women (6). Self-efficacy for coping was crucial when dealing with fatal disease and 
unwanted cancer treatment. It is associated with QoL, the higher the self-efficacy for coping, the 
better the QoL (7).   
Self-efficacy for coping and QoL in various type of cancers were extensively studied 
worldwide (8) especially breast cancer. However, there was no study found in Malaysia. 
Therefore, self-efficacy for coping and QoL need to be evaluated further to identify the level of 
self-efficacy for coping in breast cancer population, and its association with socio-demography 
and clinical factors.  
 There were many tools to measure the self-efficacy for coping and QoL in breast cancer 
women such as Brief Cancer Behavior Inventory (CBI-B) (9, 10) and Long Cancer Behavior 
Inventory (CBI-L) (11). The CBI-L was widely used however CBI-B was chosen because it is 
easy and simple tool to be used, reliable and valid to measure the self-efficacy for coping in 
cancer patients. The CBI-L contained 33 items, so it is time consuming for cancer patients to 
answer. 
The QoL also important components in breast cancer women and in this study it was 
measured by using Malay version “European Organization for Research and Treatment of 
Cancer (EORTC) questionnaire (QLQ-C30 and QLQ-BR23) (12). 
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1.2 Justification and rationale 
 
This research is conducted to determine the self-efficacy for coping and quality of life (QoL) in 
breast cancer women in Kelantan within 3 years of diagnosis. The aim of this study was to gain 
the information regarding self-efficacy for coping and QoL in breast cancer women, its 
associated factors, mean score of the QoL subscales and the correlation between self-efficacy for 
coping and QoL. The participants selected within 3 years of diagnosis because no previous study 
done within this time frame. In addition, we might face inadequate numbers of participants if 
breast cancer women were chosen within a very short duration of cancer diagnosis such as within 
1 or 2 years after diagnosed with cancer. There were studies done within one year of breast 
cancer diagnosis (11), and other studies done within one to five years of diagnosis (13). However 
most of the studies did not have a specific duration of the breast cancer diagnosis for their 
participants (14). 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Self-efficacy  
 
Self-efficacy is defined as an individual’s self-judgment about his/her capacity to be able 
to organize the necessary activities to successfully demonstrate a specific performance. The 
higher the level of self-efficacy, the greater the performance accomplishments (15). Self-efficacy 
determines how a person thinks, feels, motivates and performs certain actions. Therefore, it is an 
important concept in accepting cancer diagnosis and symptoms’ management related with 
disease and its treatment.  
Self-efficacy is an important component of Social Cognitive Theory where it is becoming 
recognized for its significant effect on patients’ adaptation to their illness and self-care behavior 
(8). Self-efficacy theory is developed based on four principals; performance attainment (direct 
mastery experiences), vicarious experiences (observing the performance of others), verbal 
persuasion, and lastly arousal state (physiological states to partly judge their capability, strength, 
and vulnerability). The performance attainment is the most powerful factor of self-efficacy based 
on previous personal accomplishments and success. If self-efficacy is lacking, people tend to 
behave ineffectively even though they know what to do (15).  
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2.1.1 Self-efficacy for coping with cancer 
 
 
 The self-efficacy for coping has a similar meaning with self-efficacy. It is regarding a 
person’s subjective appraisal of her/his ability to cope with the environmental demands on the 
stressful situation (15). Coping refers to a behavior that protects people from being 
psychologically harmed by problematic social experience (16). Previous studies have shown that 
cancer patients who reported greater self-efficacy in coping with their disease were better 
adjusted and have better QoL as compared to the patients with lower self-efficacy (9, 17). 
Various factors contribute to the reduction of the coping abilities in patients with cancer such as 
pain (18), fatigue, cancer symptoms and treatment, depression and anxiety (19). However, a 
person has different capability to self-manage their symptoms, psychological and emotional 
response to accept and cope with cancer and cancer-related side effects. One of the studies 
showed that women diagnosed with non-invasive breast cancer also experience powerful 
emotions once they were diagnosed with cancer and religious practice was used to increase a 
person’s coping level (20). 
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2.2 The duration of the cancer diagnosis on the self-efficacy for coping and quality of life 
 
 The self-efficacy for coping and QoL of cancer patients are affected by various factors, 
ranging from diagnosis (21) , stage of disease, the type of treatment the patients get, depression, 
and spiritual beliefs. 
The self-efficacy for coping is a dynamic process and it fluctuates from time to time (15), 
since the time of the diagnosis given, during treatment and after completing the treatment. The 
self-efficacy for coping was beneficial in breast cancer survivors because it contributed for better 
mental health and more positivity in battling to fight with cancer. Therefore, based on Bandura 
theory, self-efficacy for coping was increased after longer duration of cancer diagnosis (15). 
However, a study by Rottmann and friends showed that longer time since diagnosis associated 
with poorer self-efficacy (β=-0.64, p=0.0007). They reported poorer self-efficacy for coping in 
their study possibly due to their breast cancer women were delayed in attending the rehabilitation 
course, therefore their participants distressed and had a poor self-efficacy for coping (22).  
The self-efficacy is influenced by early or delayed in breast cancer confirmation. A study 
in Taiwan showed that women who delayed a breast cancer evaluation had a decrease of self-
efficacy after surgery while those who did not delay had an inverse result. From their study, 
anxiety and depression significantly reduced the self-efficacy in their women (23).  
Regarding the relationship in between duration of cancer diagnosis and QoL, a study in 
the United States showed that in an average of three years after diagnosis, breast cancer women 
were coping well with cancer diagnosis and the participants QoL scored were similar to the 
general adult United States population (24). However, a study by Bernhard and friends showed 
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that the global QoL was poor in breast cancer women within first 2 years of diagnosis and after 5 
years of complete treatment. The reason for poor global QoL in breast cancer women within 2 to 
5 years of diagnosis due to the fear for the possible relapse and depressive reactions after being 
diagnosed with cancer (25).  
 Mastectomy procedure also significantly reduced the QoL in breast cancer survivors. A 
study by Steeg et al shows that after 4 to 5 years following mastectomy, the QoL in breast cancer 
women was still impaired. This is because following mastectomy, breast cancers women 
experiences pain at the surgical site, lymphedema, and numbness (26). However, from Arndt et 
al study in Germany showed that the global QoL comparable with general population women 
after one year of breast cancer diagnosis. Their global QoL scores were comparable with scores 
in women without breast cancer because global QoL were assessed after the acute treatment-
related side effects (chemotherapy) disappeared. However certain sub-domains such as 
emotional, social, role and cognitive functioning QoL were still impaired (11). 
 
2.3 Associated factors for self-efficacy for coping in breast cancer 
 
2.3.1 Socio-demographic factors  
 
There were several studies showed that self-efficacy for coping were significantly 
associated with age (17), education and time since diagnosis (22). The self-efficacy for coping 
also had a protective effects on the unemployment, mastectomy, and co-morbidity (13). Marital 
status, economic status, types of breast surgery, and adjuvant chemotherapy had an association 
with coping mechanism based on qualitative study by Suriati et al (27).  
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Regarding the educational level, a study done in Malaysia showed that individuals with 
higher educational levels have more comprehensive ways when approaching problems related to 
breast cancer diagnosis and treatment. The level of awareness about breast cancer increased in 
women with high educational level, and they were more alert with breast cancer screening and 
breast cancer symptoms (28).  
Marital status and support from closed family members were significant factors in coping 
with breast cancer diagnosis and treatment (29, 30). The spouse role in taking over the role as a 
home manager is important to help the women to cope with cancer diagnosis. This reversal role 
is important for the family dynamics because the cancer treatment causes a negative impact on 
the women’s role as a home manager. The emotional support from spouse and family members 
were important for them to share their fears, anxieties and uncertainty about cancer (31). 
The religious (32), racial and cultural norms were important influences in coping with 
breast cancer (30, 33). A study among Chinese ethnic in Malaysia (34) and Muslims community 
(35) found that relying on God and religion helped them to cope better, increased their spiritual 
well-being, and less distress with fatal disease. Not only in our country, several studies such as in 
Thailand (36), Lebanese (37) and other countries showed similar findings. However, we did not 
specifically measure these factors in our study.   
 Everyone believes cancer is incurable and it is a fatal disease even though after seeking 
appropriate treatment. A study by Vivien et al showed that Malaysian Chinese socio-cultural 
beliefs and practices played a role in health-seeking behaviors, the ways of living and how they 
handling a cancer diagnosis. From the study, not only religion but positive thinking and 
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Complementary and Alternative Medicine helped them to release the pain and discomfort caused 
by the illness (34).  
Personality trait was another significant factors associated with self-efficacy for coping in 
breast cancer women. From Taiwan study, personality trait in their women leads to delay in 
confirming a breast abnormality and women tend to neglect the abnormality and preferred herbs 
remedies, folk therapies and religious ceremony. They believe that herbs cured them without 
systemic unwanted side effects, thus medical advice is not essential for them (23). A study by 
Suriati et al also mentioned that socio-cultural and psychological factors in Malaysian women 
contributes for late screening and treatments (28). 
 
2.3.2 Clinical characteristics factors 
 
Clinical characteristic of breast cancer, such as cancer stage at diagnosis (17), types of 
surgery, comorbidity (13) and cancer treatment (chemotherapy and radiation therapy) (17) were 
associated with self-efficacy for coping. Women diagnosed with breast cancer at an earlier stage 
of diagnosis had better coping process when compared with women who came with late cancer 
diagnosis. In the earlier stage of breast cancer, a mass was confined to the breast area without 
ulcer or skin inflammation as compared with advanced cancer stage.  
Mastectomy is the commonest treatment of choice in low and middle income countries 
compared with Breast Conservative surgery (BCS). Despite low cost, unavailability of new 
treatment, and late cancer presentation were the main reasons for that (3). In Malaysia, the 
majority of our breast cancer women delayed in seeking medical intervention and came with 
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bigger lump at presentation as well as with distant node metastasis (38). Therefore, mastectomy 
in combination with systemic chemotherapy or radiotherapy is the choice in the majority of our 
patients. Conversely with Singapore, introduction of the mammogram breast screening starting 
from the year 2002 showed the increasing of the breast cancer awareness among their women 
and most of them present at an earlier stage of cancer with smaller tumors (39).  
 Breast cancer surgery especially mastectomy were related with poor self-efficacy for 
coping. A study by Chang and friends among Taiwanese breast cancer women showed that their 
participants who delayed in breast cancer confirmation had lower self-efficacy level after 
surgery. This is because the longer they delayed the diagnosis, more advanced the cancer stage 
(23).  
 Chemotherapy is significantly associated with negative coping level as compared with 
radiotherapy and hormonal treatment. A study by Saniah and friends in Malaysia, involving 141 
participants showed that women on chemotherapy had high level of depressive and anxiety 
symptoms, therefore they cope with cancer treatment by using religion, acceptance of the 
disease, and emotional support (33). 
Regarding hormonal treatment, a study by Shelby et al found that higher self-efficacy for 
coping with symptoms in the study associated with greater functional, emotional, and social 
well-being of QoL (40). 
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Radiotherapy was well-tolerated by breast cancer women because it carries minimal 
serious morbidity. After the Breast Conservative surgery (BCS), radiotherapy treatment was 
indicated for breast cancer women because it significantly reduces the risk of local recurrence, 
reduced distant metastasis and improves survival (41). However, a study in Greece showed that 
after receiving the radiation therapy, the self-efficacy and QoL scored were reduced in their 
participants because of elevated anxiety scores. They used different questionnaire for self-
efficacy for coping and QoL as compared with our study (42). 
 
2.3.3 The Cancer Behavior Inventory (CBI) 
 
 
The Cancer Behavior Inventory questionnaire is developed as a comprehensive measure 
of self-efficacy for coping in cancer patients. The first revision of CBI contained 43 items, and 
had evolved into a revised shorter 33 items (43). The CBI became even shorter and more 
convenient to use with the 14 items version (9).  
Apart from the CBI, there are also other numerous tools to asses’ self-efficacy for coping 
(14, 44). However, in this study the 14 items of the CBI-B questionnaire was chosen because it is 
simple and less burden to a cancer patient to answer. In addition, the reliability of the CBI-B was 
similar with the CBI-L (9).  
Regarding the CBI-L questionnaire, it contained 33 items and divided into 7 domains 
which is maintaining activity and independence, seeking and understanding medical information, 
stress management, coping with treatment related side effects, accepting cancer/maintaining a 
positive attitude, affective regulation, and seeking social support. The CBI-L is a reliable 
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measures with good Cronbach alpha (0.94) (43). The CBI-L (Malay version) was validated with 
good Cronbach alpha (ranged 0.368 to 0.829) and in the process of publication.   
The Cancer Behavior Inventory (CBI) questionnaire either long or short version are 
assessed on a 9-point Likert scale, ranging from 1 to 9. ‘1’ means not at all confident and ‘9’ 
means totally confident. Item scores are added to give a total score and the higher the scores 
indicating the greater the self-efficacy for coping.  
Regarding the brief Cancer Behavior Inventory (CBI-B) (9), it contained 14 items 
derived from 33-item of the Cancer Behavior Long (CBI-L). The CBI-B questionnaire was 
developed to reduce burden to the cancer’s patient to answer as compared with CBI-L. The 
psychometric analysis showed the internal consistency for CBI-B were good ranging from 0.84 
to 0.88 (9). There were high correlation in between the CBI-B and CBI-L (r=0.95, p<0.001). In 
Heitzmann’s study, 2 items were eliminated from the 14-item CBI-B which is item number 5 and 
number 14 because it did not load well on the factors. Finally, the CBI-B contained 12-item and 
divided into 4 domains. First domain was the “belief about maintaining independence and 
positive attitude”, second domain was “belief in their ability to participate in medical care”, third 
domain was “skills important for coping and stress management”, and fourth domain was 
regarding their “capacity to manage their emotions/affect in difficult situations”. 
The psychometric analysis and validity of the CBI-B (Malay version) questionnaire was 
conducted. The reliability was good with Cronbach alpha ranging from 0.789 and 0.916 for each 
domain. Therefore, the CBI-B questionnaire is suitable to be used among Malay majority 
population.   
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2.4 Quality of life in breast cancer  
 
 There is no specific definition for quality of life (QoL). It is multidimensional and 
holistic including the social, emotional and physical well-being of patients. However, World 
Health Organization (WHO) defined quality of life as an individual’s perception of his position 
in life in the context of the culture and value systems in which he or she lives and in relation to 
his goals, expectations, standards and concerns (45).  
 The QoL does not only measure breast cancer survivors but other types of cancer such as 
prostate cancer (46), colorectal cancer, and lung cancer (17). In breast cancer survivors, the 
impact of both intervention and disease on a patient’s lifestyle or QoL are increasingly 
recognized (47). In developed countries, there were lots of studies done regarding the QoL 
and/or coping mechanism including self-efficacy for coping, psychological and psychosocial 
concerns in certain duration of cancer diagnosis such as in newly diagnosed breast cancer, one 
year after diagnosis and for the long term survivors (more than 5 years after the diagnosis). In 
our country and other less developed nations in contrast, less attention paid and studies 
conducted.  
 The QoL questionnaire contained few subscales such as in the European Organization for 
Research and Treatment of Cancer (EORTC) questionnaire, it were divided into global, 
functional and symptoms. Evidence showed that breast cancer survivors have significant 
problems with certain domain of QoL such as global QoL, pain, arm symptoms, and body image 
after long duration of cancer treatments (6). Similarly, Bernhard et al found emotional, social 
and sexual functioning deterioration in breast cancer survivors within 1 to 2 years after cancer 
diagnosis and more than 5 years after the disease-free (25).  
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 In Taiwan study, breast cancer women (n=37) who did the Breast Conservative surgery 
(BCS), showed worse global QoL, low role functioning scores, higher symptomatic scores for 
fatigue, pain, dyspnea, appetite loss, breast and arm problems (48). In line with Spain study in 
(n=108) Caucasian women in the mean age 49.2 ± 8.2 years old showed significant associations 
for cancer-related fatigue, physical activity, systemic side effects and body image with depressed 
mood in their breast cancer survivors (49). 
A study by Arndt et al showed that one year after the diagnosis of breast cancer patient 
the physical, cognitive and social functioning QoL subscales were less affected. However, the 
emotional functioning QoL scored the lowest and almost 90% of their participants complaining 
of having depressed, irritable, and worried. Most of them reported that they were severely 
affected by ‘fatigue’ (80%), ‘insomnia’ (65-70%) and ‘pain’. While other symptoms such as 
‘nausea and vomiting’, ‘constipation’, ‘diarrhea’ and ‘appetite loss’ were less frequently reported 
(15-20%) (11). 
 In conclusion, the QoL impact in breast cancer survivors was widely studied and certain 
subscales were identified to be significant. In view of that, we are interested to study which QoL 
scores were significant in breast cancer women in Hospital Universiti Sains Malaysia. 
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2.5 Correlation between self-efficacy for coping and quality of life 
 
Evidence showed that greater self-efficacy for coping is linked to the better QoL in breast 
cancer survivors (9, 14). To our knowledge, no study was found assessing self-efficacy for 
coping using brief cancer behavior inventory (CBI-B) and European Organization for Research 
and Treatment of Cancer quality of life questionnaires (EORTC). However, there were studies 
found measuring the self-efficacy for coping and QoL by using other tools (8, 11). 
  A study by Heitzmann et al showed self-efficacy for coping with cancer significantly 
correlated with QoL used the Functional Assessment of Cancer Therapy Scale (FACT-G) 
questionnaire. The self-efficacy for coping was related with four domains of QoL; physical, 
social/family, emotional and functional well-being (9). 
 Another study by Cunnigham et al found positive correlation between perceived self-
efficacy and QoL using the Stanford Inventory of Cancer patient Adjustment and Functional 
living Index-cancer questionnaires (14).  
 Not only limited to breast cancer survivors, there was a study done in prostate cancer 
patients. The results showed that, prostate cancer survivors who reported better general health 
QoL rated their self-efficacy for higher symptoms control. Not only patients, but partners also 
presented with similar results. Therefore, higher self-efficacy in patients related with less 
partners anxiety and less caregiver strains. They used the Self-efficacy for symptoms control 
questionnaire and specific QoL tools for prostate cancer (46).  
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 A study by Porter et al in United States involved 150 lung cancer patients and their 
informal caregivers showed both of them had relatively lower self-efficacy scores. Patients and 
caregivers who were low in self-efficacy scores had significantly higher pain, and fatigue 
symptoms. They also had low physical and functional QoL scores. They found lower self-
efficacy in lung cancer caregivers associated with higher levels of caregivers strain (17).    
 Based on above evidences, this study was conducted to determine the correlation between 
the self-efficacy for coping and the QoL in breast cancer women. And, we are more interested to 
know whether breast cancer women in Kelantan presented with similar or different results.    
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CHAPTER 3: OBJECTIVES 
 
3.1 General objectives 
To determine the self-efficacy for coping and quality of life in women with Breast Cancer       
in Hospital Universiti Sains Malaysia. 
 
3.2 Specific objectives 
1. To determine the mean scores of self-efficacy for coping in women with breast cancer 
in Hospital Universiti Sains Malaysia. 
2. To determine the association between socio-demography and clinical factors with   
                 self-efficacy for coping in women with breast cancer in HUSM.  
3. To determine the mean scores of quality of life in women with breast cancer in  HUSM 
4. To determine the correlation between self-efficacy for coping and quality of life in 
women with breast cancer.  
 
3.3 Research hypotheses 
1. The self-efficacy for coping score in women with breast cancer was significantly related with 
socio-demographic and clinical characteristic variables.   
2. The self-efficacy for coping had a significant linear positive/negative correlation on the quality 
of life in women with breast cancer. 
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CHAPTER 4: METHODOLOGY 
 
4.1 Study design 
 
This is a cross sectional study done from January 2012 to December 2012. 
 
4.2 Study area 
 
This study conducted at Oncology Clinic and Radiotherapy Unit in HUSM. The Oncology clinic 
and Radiotherapy Unit is started since 1996 and received various type of cancer’s patients such 
as breast cancer, gastrointestinal cancer, and others. Most of the patients were from East Coast of 
Malaysia which is from Kelantan, Terengganu and Pahang. The Oncology clinic was conducted 
by 1 Oncologist, 4 medical officers, 12 staff nurses and 2 oncology’s counselors. Total daily 
patient attendance at the Oncology clinic was 30 patients and about 10 to 15 cases were breast 
cancer patients. The Oncology clinic also provides a day-care center for chemotherapy care of 
breast cancer women. The Radiotherapy Unit was run by 5 staffs, including one Oncologist. 
Daily breast cancer patient attendance was about 20 to 30 patients.  
 
4.3 Population and sample 
4.3.1 Reference population 
Women with breast cancer in HUSM.  
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4.3.2 Source population 
Women with breast cancer in HUSM who attended the Oncology Clinic and Radiotherapy Unit 
in HUSM  
 
4.3.3 Study population 
Women with breast cancer in HUSM who attended the Oncology Clinic and Radiotherapy Unit 
in HUSM and confirmed of breast cancer from January 1, 2009 and December 31, 2012. 
 
4.3.4 Inclusion Criteria  
 
1. Age > 18 years old 
2. Histologically confirmed breast cancer patient and get treatment at HUSM. 
3. Diagnosed of breast cancer from January 1, 2009 and December 31, 2012 (within 3 years of 
diagnosis)  
 
4.3.5 Exclusion criteria  
 
1. Illiterate 
2. Diagnosed as cognitive impairment 
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4.3.6 Sampling method 
 
This study used universal sampling method in view of inadequate numbers of patients for a 
random sampling during the study period. 
 
4.3.7 Sample size  
 
The sample size was calculated for each objective. The biggest sample size was taken as the 
study sample size. 
 
 Objective 1 
To determine the mean scores of coping self-efficacy in women with breast cancer in Kelantan 
using single mean formula (9); 
 n =  (z (ơ/∆)2 
Z = 1.96 
 σ = population standard deviation (SD) 
            Δ = the estimation precision of the population mean  
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Table 1: Sample size calculation for objectives 1 
 
 
CBI-B item SD Precision Sample size (n) 10% non-response 
Expressing negative feeling 
about cancer  
2.17 0.35 148 177 
Seeking help 1.86 0.30 147 176 
Based on objectives 1, the maximum required women needed in this study were 177. 
 
Objective 2 
To determine the relationship between socio-demographic and clinical factors and coping self-
efficacy in women with Breast cancer in HUSM. Sample size calculation was using Power and 
Sample Size Calculation software.  
Based on 95% confidence Interval, α or error was set at 5 percent or 0.05 
The power of the study was set at 80 percent or 0.08. 
Table 2: Sample calculation for objectives 2 
Variables P0 is the 
probability of the 
outcome for a 
control patients 
P1 is the 
probability of the 
outcome in an 
experimental 
subject 
m is a ratio of 
control to 
experimental 
subjects 
Expected 
number of 
respondents, 
n 
Reference 
Age 
 
42% 65% 1 146 (44) 
Education 
 
72% 50% 1 152 (13) 
Employed 
 
40% 65% 1 122 (13) 
Surgery 
(mastectomy) 
35% 60% 1 122 (50) 
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Objective 3 
To determine the mean scores of quality of life (QoL) in women with Breast cancer in HUSM 
using single mean formula (11); 
 n = (z (ơ/∆)2 
Z = 1.96 
 σ = population standard deviation (SD) 
               Δ = the estimation precision of the population mean  
Table 3: Sample calculation for objectives 3 
 
Items  SD Precision Sample size (n) 
Global QOL 22.0 5.0 74 
 
1. Functional Scale 
 
Physical functioning 21.7 5.0 72 
Role functioning 29.3 6.0 131 
Emotional functioning 29.0 6.0 129 
Cognitive functioning 27.6 6.0 117 
Social functioning 29.0 6.0 129 
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Objective 4 
 
To determine the correlation between self-efficacy for coping and QoL in women with Breast 
cancer in HUSM. Sample size calculation was using Power and Sample Size Calculation 
software. However, due to inadequate data from the literature, this sample size has not been able 
to be calculated. Based on expert opinion, the number of sample size based on objectives 4 was 
less than objectives 1, 2 and 3. 
 
As a conclusion, the maximum required sample after considering 10% non-response rate was 
177 based on sample size calculation for objectives 1 
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4.3.8 Operational definitions  
 
1. Self-efficacy for coping  
means an individual’s self judgement about his/her capacity to be able to organize the 
necessary activities to successfully demonstrate a specific performance by using brief 
Cancer Behavior Inventory (CBI-B) questionnaire (15). 
 
2. Quality of life  
is an individual’s perception of his/her position in life in the context of the culture and 
value systems in which he lives and in relation to his/her goals, expectations, standards 
and concerns by using European Organization for Research and Treatment of Cancer  
(EORTC) QLQ-C30 and QLQ BR-23 questionnaires (45). 
 
3. Breast cancer  
means confirmed by histologically findings based on ICD-10. 
 
4. Living arrangement 
means a husband or informal caregivers (17) who were living together and  taking care of 
their spouse or relatives with breast cancer.  
 
5. Menstrual cycle irregularities  
means oligomenorhea, and amenorrhea (primary and secondary include menopause and 
premature menopause following cancer treatment). 
 
